Your browser doesn't support javascript.
loading
Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study.
Fulgenzio, Chiara; Massari, Marco; Traversa, Giuseppe; Da Cas, Roberto; Ferrante, Gianluigi; Aschbacher, Richard; Moser, Verena; Pagani, Elisabetta; Vestri, Anna Rita; Massidda, Orietta; Kurotschka, Peter Konstantin.
Afiliação
  • Fulgenzio C; Department of Public Health and Infectious Diseases, Postgraduate School of Medical Statistics and Biometry, University of Rome "La Sapienza", 00185 Rome, Italy.
  • Massari M; Pharmacoepidemiology Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Traversa G; Pharmacoepidemiology Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Da Cas R; Agenzia Italiana del Farmaco, 00187 Rome, Italy.
  • Ferrante G; Pharmacoepidemiology Unit, National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, 00161 Rome, Italy.
  • Aschbacher R; Azienda Ospedaliera, Universitaria Città della Salute e della Scienza di Torino, 10126 Turin, Italy.
  • Moser V; Health Service of Bolzano/Bozen Province, 39100 Bolzano/Bozen, Italy.
  • Pagani E; Health Service of Bolzano/Bozen Province, 39100 Bolzano/Bozen, Italy.
  • Vestri AR; Health Service of Bolzano/Bozen Province, 39100 Bolzano/Bozen, Italy.
  • Massidda O; Department of Public Health and Infectious Diseases, Postgraduate School of Medical Statistics and Biometry, University of Rome "La Sapienza", 00185 Rome, Italy.
  • Kurotschka PK; Department of Cellular, Computational and Integrative Biology, University of Trento, 38123 Povo, Italy.
Antibiotics (Basel) ; 10(4)2021 Apr 16.
Article em En | MEDLINE | ID: mdl-33923682
ABSTRACT
Research is lacking on the reversibility of antimicrobial resistance (AMR). Thus, we aimed to determine the influence of previous antibiotic use on the development and decay over time of third generation cephalosporin (3GC)-resistance of E. coli. Using the database of hospital laboratories of the Autonomous Province of Bolzano/Bozen (Italy), anonymously linked to the database of outpatient pharmaceutical prescriptions and the hospital discharge record database, this matched case-control study was conducted including as cases all those who have had a positive culture from any site for 3GC resistant E. coli (3GCREC) during a 2016 hospital stay. Data were analyzed by conditional logistic regression. 244 cases were matched to 1553 controls by the date of the first isolate. Male sex (OR 1.49, 95% CI 1.10-2.01), older age (OR 1.11, 95% CI 1.02-1.21), the number of different antibiotics taken in the previous five years (OR 1.20, 95% CI 1.08-1.33), at least one antibiotic prescription in the previous year (OR 1.92, 95% CI 1.36-2.71), and the diagnosis of diabetes (OR 1.57, 95% CI 1.08-2.30) were independent risk factors for 3GCREC colonization/infection. Patients who last received an antibiotic prescription two years or three to five years before hospitalization showed non-significant differences with controls (OR 0.97, 95% CI 0.68-1.38 and OR 0.85, 95% CI 0.59-1.24), compared to an OR of 1.92 (95% CI 1.36-2.71) in those receiving antibiotics in the year preceding hospitalization. The effect of previous antibiotic use on 3GC-resistance of E. coli is highest after greater cumulative exposure to any antibiotic as well as to 3GCs and in the first 12 months after antibiotics are taken and then decreases progressively.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article